News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
162,294 Results
Type
Article (8939)
Company Profile (38)
Press Release (153313)
Multimedia
Podcasts (25)
Webinars (5)
Section
Business (45746)
Career Advice (145)
Deals (8045)
Drug Delivery (48)
Drug Development (20898)
Employer Resources (12)
FDA (4630)
Job Trends (2731)
News (80897)
Policy (9060)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (525)
Accelerated approval (28)
ADA (6)
Adcomms (11)
Allergies (76)
Alliances (15746)
ALS (65)
Alzheimer's disease (491)
Antibody-drug conjugate (ADC) (248)
Approvals (4700)
Artificial intelligence (234)
ASCO (91)
Autoimmune disease (159)
Automation (20)
Bankruptcy (29)
Best Places to Work (2189)
BIO (24)
BIOSECURE Act (17)
Biosimilars (202)
Biotechnology (31)
Bladder cancer (86)
Brain cancer (23)
Breast cancer (209)
Cancer (1853)
Cardiovascular disease (93)
Career advice (132)
Career pathing (6)
CAR-T (76)
CDC (14)
Cell therapy (282)
Cervical cancer (17)
Clinical research (19092)
Collaboration (853)
Company closure (3)
Compensation (146)
Complete response letters (50)
COVID-19 (752)
CRISPR (18)
C-suite (330)
Cystic fibrosis (26)
Data (2684)
Denatured (6)
Depression (35)
Dermatology (45)
Diabetes (134)
Diagnostics (1255)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (167)
Drug pricing (42)
Drug shortages (1)
Duchenne muscular dystrophy (123)
Earnings (17334)
Editorial (24)
Employer branding (3)
Employer resources (10)
Events (19729)
Executive appointments (261)
FDA (6026)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (12)
Funding (505)
Gene editing (64)
Generative AI (31)
Gene therapy (256)
GLP-1 (240)
Government (1590)
Grass and pollen (2)
Guidances (116)
Healthcare (2931)
Hematology (64)
HIV (24)
Huntington's disease (23)
IgA nephropathy (42)
Immunology and inflammation (117)
Immuno-oncology (51)
Indications (71)
Infectious disease (873)
Inflammatory bowel disease (102)
Inflation Reduction Act (7)
Influenza (54)
Intellectual property (86)
Interviews (11)
IPO (3237)
IRA (16)
Job creations (606)
Job search strategy (122)
JPM (11)
Kidney cancer (7)
Labor market (8)
Layoffs (78)
Leadership (4)
Legal (1455)
Liver cancer (32)
Longevity (23)
Lung cancer (279)
Lymphoma (147)
Machine learning (25)
Management (2)
Manufacturing (520)
Marketing (2)
MASH (53)
Medical device (2265)
Medtech (2307)
Mergers & acquisitions (5177)
Metabolic disorders (339)
mRNA (58)
Multiple sclerosis (64)
NASH (3)
Neurodegenerative disease (136)
Neuropsychiatric disorders (15)
Neuroscience (947)
NextGen: Class of 2026 (898)
Non-profit (426)
Now hiring (18)
Obesity (126)
Opinion (82)
Ovarian cancer (84)
Pain (51)
Pancreatic cancer (77)
Parkinson's disease (118)
Partnered (14)
Patents (167)
Patient recruitment (203)
Peanut (32)
People (12905)
Pharmaceutical (11)
Pharmacy benefit managers (8)
Phase 1 (5902)
Phase 2 (8031)
Phase 3 (6977)
Pipeline (3397)
Policy (141)
Postmarket research (515)
Preclinical (2260)
Press Release (66)
Prostate cancer (79)
Psychedelics (10)
Radiopharmaceuticals (72)
Rare diseases (372)
Real estate (1435)
Recruiting (4)
Regulatory (8233)
Reports (13)
Research institute (491)
Resumes & cover letters (12)
Rett syndrome (12)
RNA editing (9)
RSV (20)
Schizophrenia (46)
Series A (99)
Series B (64)
Service/supplier (4)
Sickle cell disease (34)
Special edition (6)
Spinal muscular atrophy (29)
Sponsored (20)
Startups (955)
State (1)
Stomach cancer (7)
Supply chain (34)
Tariffs (21)
The Weekly (19)
Vaccines (388)
Venture capital (24)
Weight loss (61)
Women's health (21)
Date
Today (50)
Last 7 days (171)
Last 30 days (759)
Last 365 days (8542)
2026 (4700)
2025 (8083)
2024 (8898)
2023 (9902)
2022 (14512)
2021 (14557)
2020 (13046)
2019 (9070)
2018 (7026)
2017 (8086)
2016 (7297)
2015 (8784)
2014 (6389)
2013 (5138)
2012 (5445)
2011 (5710)
2010 (4996)
Location
Africa (173)
Alabama (22)
Alaska (1)
Arizona (43)
Arkansas (4)
Asia (26575)
Australia (3160)
California (3463)
Canada (939)
China (833)
Colorado (65)
Connecticut (107)
Delaware (129)
Europe (26114)
Florida (465)
Georgia (71)
Hawaii (1)
Idaho (14)
Illinois (165)
India (70)
Indiana (97)
Iowa (11)
Japan (394)
Kansas (13)
Kentucky (16)
Louisiana (5)
Maine (13)
Maryland (609)
Massachusetts (2526)
Michigan (46)
Minnesota (123)
Mississippi (4)
Missouri (30)
Montana (5)
Nebraska (4)
Nevada (28)
New Hampshire (7)
New Jersey (1265)
New Mexico (4)
New York (923)
North Carolina (451)
North Dakota (10)
Northern California (1679)
Ohio (85)
Oklahoma (12)
Oregon (7)
Pennsylvania (520)
Puerto Rico (6)
Rhode Island (8)
South America (236)
South Carolina (5)
Southern California (1503)
Tennessee (15)
Texas (476)
United States (11870)
Utah (83)
Vermont (1)
Virginia (92)
Washington D.C. (10)
Washington State (264)
West Virginia (1)
Wisconsin (24)
162,294 Results for "cobra biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Advancing efficiency and alignment in biologics development, through product-specific methods, to support broader availability of biologics, including biosimilars, for patients
June 1, 2026
·
4 min read
Press Releases
TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets Globally
Expands Latin America presence with strategic partnership with Mobil Saúde and builds on TempraMed’s recently granted Brazilian patent portfolio Highlights: TempraMed signs Agreement for exclusive distribution in Brazil with Mobil Saúde Comercial Ltda Brazil represents one of the world’s largest markets for diabetes, GLP-1 therapies, and temperature-sensitive biologics1. Diabetes market alone reached USD $2.15 Billion in 2025 Partnership builds on TempraMed’s recently granted Brazilian patent protecting the VIVI Box™ platform Expands TempraMed’s commercialization footprint across Latin America following recent regional expansion initiatives
June 4, 2026
·
10 min read
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
May 6, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Special Rights attached to the First and Second Tranche of Bonds
May 28, 2026
·
3 min read
Press Releases
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
June 30, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Results of the Annual General Meeting
May 4, 2026
·
6 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth
June 30, 2026
·
4 min read
1 of 16,230
Next
